Bioventix PLC (LON:BVXP – Get Free Report) reached a new 52-week low on Monday . The stock traded as low as GBX 2,400 ($31.03) and last traded at GBX 2,420 ($31.29), with a volume of 26011 shares traded. The stock had previously closed at GBX 2,750 ($35.55).
Bioventix Trading Down 1.0 %
The stock has a market capitalization of £125.67 million, a price-to-earnings ratio of 15.52 and a beta of 0.35. The business has a 50 day simple moving average of GBX 2,879.90 and a 200-day simple moving average of GBX 3,347.62.
Bioventix (LON:BVXP – Get Free Report) last released its earnings results on Monday, March 31st. The biotechnology company reported GBX 72.27 ($0.93) earnings per share (EPS) for the quarter. Bioventix had a net margin of 59.51% and a return on equity of 69.09%. Research analysts predict that Bioventix PLC will post 166.3066955 EPS for the current year.
About Bioventix
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.
Recommended Stories
- Five stocks we like better than Bioventix
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- How to Invest in the Best Canadian Stocks
- The 3 Most Talked About Investments on WallStreetBets Right Now
- Growth Stocks: What They Are, Examples and How to Invest
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.
